The WVU Cancer Institute will begin enrolling its first patients in a National Institute of Health (NIH) Beau Biden Moonshot Initiative trial on Oct. 25 as part of a consortium of six U.S. healthcare systems with the goal of integrating the use of patient-reported outcomes into the routine practice of oncology.
Abraham Kanate, MD, Medical Director for the Osborn Hematopoietic Malignancy and Cellular Therapy Program and Associate Professor recently led the consensus guidelines from the American Society of Transplant and Cellular Therapy (ASTCT) on indications for transplant and cellular therapy.
Crane lecturer Anne Swisher passed around a plush heart and asked attendees to think about something that made them excited. (APTA/Johnathan Bachman)
The second episode of "WVU and the Coronavirus" is now available for download on Apple Podcasts and Spotify.
The WVU Cancer Institute has enrolled two of the first three patients in a national clinical trial for a novel breast cancer vaccine.
WVU Cancer Institute's Cancer Prevention and Control, in collaboration with the West Virginia Cancer Registry, has released the 2019 West Virginia Cancer Burden Report. The report provides updated statewide, age-adjusted incidence rates and counts for cancer diagnosed among West Virginia residents from 2012 to 2016.
In response to the recent need for PPE for clinical healthcare workers, a local Morgantown Registered Nurse worked with a group of her college friends to raise funds and collect donations to help boost the PPE supplies for WVU Medicine and WVU Cancer Institute Cancer Clinical Trials Research Unit
Goldberg honored for work in GI Cancers by OncLive® and The Ruesch Center for the Cure of Gastrointestinal Cancers Names
HSC Information Technology Services will begin providing all services remotely starting Tuesday, March 17, until further notice.
